Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
复制标题
DOI：
10.1016/s0140-6736(21)00425-6
复制
发表时间：
2021-04-17
期刊：
影响因子：
--
通讯作者：
Buchan IE
中科院分区：
文献类型：
--
作者：
Mina MJ;Peto TE;García-Fiñana M;Semple MG;Buchan IE
1 Collet JP，Thiele H，Barbato E，et al. 2020 ESC无持续ST段抬高患者急性冠状动脉综合征管理指南。Eur Heart J 2020; 8月29日在线发表。网址：//doi. org/10.1093/eurheartj/ehaa575。2 Knuuti J，Wijns W，Saraste A，et al. 2019 ESC慢性冠状动脉综合征诊断和管理指南。Eur Heart J 2020; 41：407-77。3 Sibbing D，Aradi D，Alexopoulos D，et al.更新了经皮冠状动脉介入治疗中指导P2 Y12受体抑制剂治疗的血小板功能和基因检测专家共识声明。
1 Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2020; published online Aug 29. https://doi. org/10.1093/eurheartj/ehaa575. 2 Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407–77. 3 Sibbing D, Aradi D, Alexopoulos D, et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention.